https://altpep.com/new-study-for-early-detection-of-alzheimers-shows-promising-results/2024-08-16T19:56:29+00:00https://altpep.com/altpep-study-published-in-nature-journal-scientific-reports-further-affirms-potential-of-blood-test-to-detect-alzheimers-disease/2024-08-16T19:56:36+00:00https://altpep.com/2024-geekwire-awards-finalists-revealed-vote-now-for-the-best-in-pacific-northwest-tech/2024-11-11T15:41:17+00:00https://altpep.com/research-in-context-diagnosing-dementia/2024-11-11T15:41:23+00:00https://altpep.com/2023-nih-research-highlights-promising-medical-findings/2024-11-11T15:41:29+00:00https://altpep.com/altpep-further-strengthens-advisory-board-with-appointment-of-steven-e-kahn-m-b-ch-b/2024-11-11T15:41:35+00:00https://altpep.com/venture-capitalists-fund-new-generation-of-alzheimers-drugs/2024-11-11T15:41:48+00:00https://altpep.com/as-alzheimers-drugs-hit-the-market-the-race-for-early-detection-blood-tests-heats-up/2024-11-11T15:41:42+00:00https://altpep.com/alzheimers-and-parkinsons-biotech-altpep-raises-52-9m-series-b/2024-11-11T15:42:06+00:00https://altpep.com/altpep-backed-by-section32-and-lilly-gets-53m-to-catch-and-treat-early-alzheimers/2024-11-14T19:20:55+00:00https://altpep.com/altpep-corporation-announces-close-of-53-million-series-b-financing-to-advance-its-novel-therapeutics-for-both-alzheimers-and-parkinsons-diseases-into-the-clinic/2024-11-11T15:41:54+00:00https://altpep.com/altpep-wins-2023-geekwire-award-for-health-innovation-of-the-year/2024-11-11T15:42:13+00:00https://altpep.com/geekwire-awards-finalists-revealed-cast-your-vote-and-pick-the-top-pacific-northwest-innovators/2024-11-11T15:42:19+00:00https://altpep.com/altpep-strengthens-advisory-board-with-three-leading-experts-in-alzheimers-disease-and-neurodegenerative-disorders/2024-11-11T15:42:24+00:00https://altpep.com/blood-test-for-early-alzheimers-detection/2024-11-11T15:42:28+00:00https://altpep.com/soluble-oligomer-assay-rivals-other-biomarkers-in-detecting-preclinical-ad/2024-11-11T15:42:33+00:00https://altpep.com/research-article-soba-development-and-testing-of-a-soluble-oligomer-binding-assay-for-detection-of-amyloidogenic-toxic-oligomers/2024-11-11T15:42:39+00:00https://altpep.com/new-blood-test-can-identify-toxic-protein-years-before-alzheimers-symptoms-appear/2024-11-11T15:42:58+00:00https://altpep.com/alzheimers-test-could-diagnose-disease-of-exclusion-a-lot-earlier/2024-11-11T15:42:44+00:00https://altpep.com/blood-test-could-detect-alzheimers-years-before-symptoms-occur/2024-11-11T15:43:14+00:00https://altpep.com/a-new-study-in-the-proceedings-of-the-national-academy-of-sciences-pnas-demonstrates-the-ability-of-a-novel-peptide-to-selectively-detect-and-neutralize-an-early-molecular-trigger-of-alzheimer/2024-11-11T15:43:09+00:00https://altpep.com/new-blood-test-can-detect-toxic-protein-years-before-alzheimers-symptoms-emerge-study-shows/2024-11-11T15:43:04+00:00https://altpep.com/review-article-the-role-of-%ce%b1-sheet-structure-in-amyloidogenesis-characterization-and-implications/2024-11-11T15:43:20+00:00https://altpep.com/promising-data-from-large-alzheimers-study-bodes-well-for-this-seattle-startup/2024-11-11T15:43:25+00:00https://altpep.com/seattle-startup-aiming-to-detect-treat-alzheimers-and-parkinsons-disease-raises-cash/2024-11-11T15:43:31+00:00https://altpep.com/review-article-amyloid-%ce%b2-oligomers-multiple-moving-targets/2024-11-11T15:43:36+00:00https://altpep.com/altpep-receives-fda-breakthrough-device-designation-for-soba-ad-a-simple-blood-test-for-the-detection-of-alzheimers-disease/2024-11-11T15:43:41+00:00https://altpep.com/altpep-appoints-nancy-hill-to-newly-created-position-of-chief-product-officer/2024-11-11T15:43:45+00:00https://altpep.com/alzheimers-research-gets-a-boost/2024-11-11T15:43:51+00:00https://altpep.com/seattle-startup-chases-alzheimers-with-23-million-series-a/2024-11-11T15:44:06+00:00https://altpep.com/altpep-announces-closing-23-150-million-series-a-investment-round/2024-11-11T15:43:58+00:00https://altpep.com/seattle-biotech-startup-altpep-raises-23-1m-to-tackle-alzheimers-and-related-diseases/2024-11-11T15:44:12+00:00https://altpep.com/altpep-announces-that-chad-robins-joined-altpep-board-of-directors/2024-11-11T15:44:16+00:00https://altpep.com/seattle-based-life-sciences-consulting-and-incubator-company-intutive-x-joins-altpep-launch/2024-11-11T15:44:21+00:00https://altpep.com/to-fight-alzheimers-disease-univ-of-washington-researchers-target-plaque-causing-proteins/2024-11-11T15:44:31+00:00https://altpep.com/alzheimers-synthetic-protein-blocks-toxic-beta-amyloid/2024-11-11T15:44:26+00:00https://altpep.com/alzheimers-disease-toxicity-halted-by-synthetic-peptides/2024-11-11T15:44:42+00:00https://altpep.com/investment-in-research-saves-lives-and-money-series-alzheimers-fact-sheetgoes-here/2024-11-11T15:44:37+00:00https://altpep.com/altpep-corporation-welcomes-denis-sirringhaus-as-vice-president-of-business-development/2024-09-30T13:57:19+00:00https://altpep.com/with-new-support-of-private-equity-comotion-is-helping-a-uw-professors-quest-to-diagnose-alzheimers-earlier/2024-10-24T21:30:02+00:00https://altpep.com/altpep-corporation-appoints-alan-colowick-m-d-m-p-h-to-board-of-directors/2025-02-12T13:37:26+00:00https://altpep.com/gauze-containing-designed-peptide-inhibits-bacteria-biofilms/2025-03-10T15:20:34+00:00https://altpep.com/altpep-corporation-presents-new-preclinical-data-at-aaic-2025-demonstrating-sobin-ad-its-custom-designed-peptide-for-alzheimers-disease-increases-clearance-of-a%ce%b2-toxic-oligomers-and-in/2025-07-28T11:48:44+00:00https://altpep.com/altpep-corporation-presents-new-preclinical-data-at-ctad-2025-demonstrating-sobin-ad-its-custom-designed-peptide-for-alzheimers-disease-improves-behavior-in-both-symptomatic-and-asymptomati/2025-12-08T20:49:02+00:00